Pharmaceutical Industry Information Portal

HomeNewsletter

Newsletter

Russia ready to manufacture foreign anti-COVID vaccines, if need be – Denis Manturov, industry minister

It is up to the Health Ministry to decide whether to launch the production of foreign vaccines against the novel coronavirus in Russia for...

WuXi STA Passes the First U.S. FDA Drug Product Pre-Approval Inspection at its Shanghai Waigaoqiao Site

WuXi STA – a subsidiary of WuXi AppTec, announced that its Waigaoqiao site in Shanghai, China, successfully passed the first drug product pre-approval inspection...

Ascletis Pharma expands Ritonavir oral tablet production in China

Ascletis Pharma Inc. announced the expansion of the production of ritonavir oral tablets and oral direct-acting antiviral R&D pipeline for the treatment of SARS-CoV-2...

Angel Yeast Invests in New Enzyme Project Capable of 5,000 Tons Annual Production Output

Angel Enzyme Preparation (Yichang) Co., Ltd. is constructing a new green manufacturing project in Angel Biotechnology Industrial Park, Xiaoting District, Yichang City, China. Once...

Pharmasyntez to continue producing anti-COVID-19 drug remdesivir without patent for a year

The Russian government on December 30, 2021 approved the extension for one year of a decree originally issued last year to grant Russian drugmaker...

Japan Is Developing A COVID-19 Vaccine That Will Provide Lifelong Immunity

Researchers at the Tokyo Metropolitan Institute of Medical Science are working on a COVID-19 vaccine that not only delivers lifelong immunity against the SARS-CoV-2...
spot_img

Expert Articles

spot_img